Unknown News
Unknown Market News
13d
Kenvue’s Debt Restructuring Accelerates with Third Supplemental Indenture as Exchange Offer Launches
- Kenvue (NYSE: KVUE) amended its senior notes indenture on October 9 and Kimberly‑Clark has launched consent solicitations and exchange offers this week.
27d
KVUE Gains U.S. FDA Approval for Tylenol‑Naproxen OTC Combo as Merger Progresses
Kenvue (KVUE) won FDA approval for a new OTC Tylenol‑Naproxen combination with three‑year exclusivity, bolstering Q2 results amid a pending Kimberly‑Clark deal.
24 Sep at 20:31
Kenvue Declares $0.21 Quarterly Dividend as $40 B Kimberly‑Clark Takeover Faces EU Hurdles
Kenvue (NYSE: KVUE) announced a $0.21/share quarterly dividend and is navigating EU antitrust scrutiny as Kimberly‑Clark’s proposed $40 billion acquisition faces regulatory pressure.
10 Sep at 20:31
Australia Clears Kimberly‑Clark’s $40 B Acquisition of Kenvue With Carefree, Stayfree Divestment Requirement
Australia’s competition regulator has approved Kimberly‑Clark’s $40 billion bid for Kenvue, conditional on divesting Carefree and Stayfree brands—marking a pivotal step in the merger.
27 Aug at 20:31
Kenvue Shares Dip on Q2 Margin Miss, While Institutional Stake Activity Grows
Kenvue (NYSE:KVUE) missed Q2 margin expectations as inflation and tariffs weighed, while multiple institutional investors increased stakes this week.
